These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 4622959)

  • 1. A double-blind investigation of hydergine in the treatment of cerebrovascular insufficiency in the elderly.
    Rao DB; Norris JR
    Johns Hopkins Med J; 1972 May; 130(5):317-24. PubMed ID: 4622959
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hydergine in the symptomatic treatment of cerebrovascular insufficiency. Comparative clinical test with a placebo].
    Teixeira JE
    Hospital (Rio J); 1970 Jun; 77(6):1907-31. PubMed ID: 4992010
    [No Abstract]   [Full Text] [Related]  

  • 3. An ergot alkaloid preparation (hydergine) versus placebo for treatment of symptoms of cerebrovascular insufficiency: double-blind study.
    Jennings WG
    J Am Geriatr Soc; 1972 Aug; 20(8):407-12. PubMed ID: 4626496
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hydergine in the treatment of cerebral circulatory disorders, including arteriosclerosis (author's transl)].
    Lozeron H
    Schweiz Rundsch Med Prax; 1974 May; 63(21):660-5. PubMed ID: 4208744
    [No Abstract]   [Full Text] [Related]  

  • 5. An ergot alkaloid preparation (Hydergine) versus papaverine in treating common complaints of the aged: double-blind study.
    Bazo AJ
    J Am Geriatr Soc; 1973 Feb; 21(2):63-71. PubMed ID: 4631704
    [No Abstract]   [Full Text] [Related]  

  • 6. [Wallerox increases cerebral circulation and heart capacity].
    Heynen U
    Z Allgemeinmed; 1971 Dec; 47(34):1823-5. PubMed ID: 5003212
    [No Abstract]   [Full Text] [Related]  

  • 7. Symptomatic treatment of cerebrovascular insufficiency with hydergine.
    Gerin J
    Curr Ther Res Clin Exp; 1969 Sep; 11(9):539-46. PubMed ID: 4980884
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the encephalotrophic action of hydergine. Clinical study].
    Garagnani Sciarretta B; Rimondini S; Martelli A
    Minerva Med; 1974 Aug; 65(59):3090-8. PubMed ID: 4214406
    [No Abstract]   [Full Text] [Related]  

  • 9. A clinical trial comparing 'Hydergine' with placebo in the treatment of cerebrovascular insufficiency in elderly patients.
    McConnachie RW
    Curr Med Res Opin; 1973; 1(8):463-8. PubMed ID: 4204090
    [No Abstract]   [Full Text] [Related]  

  • 10. [Sympatholytic vasodilator in cerebral circulation disorders].
    Lipke PR
    Hospital (Rio J); 1969 Dec; 76(6):2159-65. PubMed ID: 4984915
    [No Abstract]   [Full Text] [Related]  

  • 11. Two trials comparing 'Hydergine' with placebo in the treatment of patients suffering from cerebrovascular insufficiency.
    Rehman SA
    Curr Med Res Opin; 1973; 1(8):456-62. PubMed ID: 4204089
    [No Abstract]   [Full Text] [Related]  

  • 12. An ergot preparation (hydergine) in the treatment of cerebrovascular disorders in the geriatric patient: double-blind study.
    Ditch M; Kelly FJ; Resnick O
    J Am Geriatr Soc; 1971 Mar; 19(3):208-17. PubMed ID: 4998602
    [No Abstract]   [Full Text] [Related]  

  • 13. [Letter: Double blind study of hydergine in aged patients].
    Paux G; Boismare F; Delaunay P
    Nouv Presse Med; 1975 Oct; 4(35):2529. PubMed ID: 812060
    [No Abstract]   [Full Text] [Related]  

  • 14. Hydergine for cerebral arteriosclerosis.
    Med Lett Drugs Ther; 1974 Mar; 16(5):21-2. PubMed ID: 4204775
    [No Abstract]   [Full Text] [Related]  

  • 15. Dihydrogenated ergot alkaloids (Hydergine) and cerebrovascular insufficiency.
    Med Lett Drugs Ther; 1970 Mar; 12(6):27-8. PubMed ID: 4994841
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical aspects on the therapy of cerebral sclerosis].
    Hoffmeister K
    Med Klin; 1967 Jun; 62(23):910-2. PubMed ID: 4970034
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effect of redergam on the cerebral circulation of patients who have suffered insults].
    Khadzhiev D
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(1):33-7. PubMed ID: 4976423
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes of the cerebral circulation time influenced by hydergine].
    Herzfeld U; Wittgen M
    Arztl Forsch; 1971 Jul; 25(7):224-30. PubMed ID: 4998670
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of patients with cerebral and diffuse arteriosclerosis with hydergine].
    Avena G
    Hospital (Rio J); 1970 Sep; 78(3):901-28. PubMed ID: 4994595
    [No Abstract]   [Full Text] [Related]  

  • 20. A double-blind evaluation of 'Hydergine' and placebo in the treatment of patients with organic brain syndrome and cerebral arteriosclerosis in a nursing home.
    Thibault A
    Curr Med Res Opin; 1974; 2(8):482-7. PubMed ID: 4217240
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.